Primary bone tumours and tumour-like lesions in children in Zaria, Nigeria
<b>Background: </b> Studies on bone neoplasms are generally scanty globally and more so in children. Primary bone tumours and tumour-like lesions in children have not been reported from Zaria. <b> Objective:</b> To determine the relative frequencies, sex and age distribution...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | African Journal of Paediatric Surgery |
Subjects: | |
Online Access: | http://www.afrjpaedsurg.org/article.asp?issn=0189-6725;year=2010;volume=7;issue=1;spage=16;epage=18;aulast=Mohammed |
Summary: | <b>Background: </b> Studies on bone neoplasms are generally scanty globally and more so in children. Primary bone tumours and tumour-like lesions in children have not been reported from Zaria. <b> Objective:</b> To determine the relative frequencies, sex and age distributions, and anatomical sites of occurrence of primary bone tumours and tumour-like lesions in children in Zaria. <b> Materials and Methods:</b> A retrospective review of histopathology reports of 40 children with bone tumours and tumour-like lesions in 11 years of age. <b> Results:</b> Benign tumours accounted for 12 (30%) of the 40 tumours reviewed (osteoma 2.5%, osterochondroma 22.5%, fibroma 5%); while malignant tumours occurred in 19 (47.5%) (osteosarcoma 5%, Burkitt′s lymphoma 37.5%, diffuse lympholastic lymphoma 5%). Tumour-like lesions accounted for 9 (22.5%), all fibrous dysplasia. Out of 40 tumours, 23 (57.5%) occurred in males and 17 (422.5%) in females. The majority of tumours, 45% occurred in the age group of 10-15 years, followed by 15 (37.5) occurring in the 5−9 years age range. The most common malignany was Burkitt′s lymphoma 15 (37.5%). Maxilla was the most common site for malignant (30%) and benign tumours (12.5%). <b> Conclusion:</b> This study has shown that, primary bone tumours are relatively uncommon in children in our setting. |
---|---|
ISSN: | 0189-6725 0974-5998 |